M

P

MARQUES-VIDAL , Pedro

Last name: MARQUES-VIDAL

First name: Pedro

2017 (v1)

Publication

Metadata-only

Impact of CD14 Polymorphisms on Anti-Apo A-1 (Apolipoprotein A-1) IgG-Related Coronary Artery Disease Prediction in the General Population

Antiochos, Panagiotis Marques-Vidal, Pedro Virzi, Julien

OBJECTIVE: We aimed to determine whether autoantibodies against apoA-1 (apolipoprotein A-1; anti-apoA-1 IgG) predict incident coronary artery disease (CAD), defined as adjudicated incident myocardial infarction, angina, percutaneous coronary revascularization, or bypass grafting, in the general population. We further investigated whether this...

Uploaded on: April 14, 2023
2017 (v1)

Publication

Metadata-only

Impact of CD14 polymorphisms on anti-apolipoprotein A-1 IGG-related coronary heart disease prediction in the general population

Antiochos, Panagiotis Marques-Vidal, Pedro Virzi, Julien

No description

Uploaded on: April 14, 2023
2020 (v1)

Publication

Metadata-only

Prognostic and therapeutic considerations of antibodies against c-ter apolipoprotein A-1 in the general population

Vuilleumier, Nicolas Antiochos, Panagiotis Marques-Vidal, Pedro

Objectives: Autoantibodies against apolipoprotein A1 (anti-apoA1 IgGs) and its C-terminal region (cter apoA1) have emerged as an independent biomarker for cardiovascular disease. Cter apoA1 mimetic peptides were shown to reverse the deleterious anti-apoA1 IgG effects in vitro. We evaluated the association of anti-cter apoA1 IgGs with overall...

Uploaded on: April 14, 2023